Issues in the pharmacokinetics of trichloroethylene and its metabolites.
Much progress has been made in understanding the complex pharmacokinetics of trichloroethylene (TCE) . Qualitatively, it is clear that TCE is metabolized to multiple metabolites either locally or into systemic circulation. Many of these metabolites are thought to have toxicologic importance. In addition, efforts to develop physiologically based pharmacokinetic (PBPK) models have led to a better quantitative assessment of the dosimetry of TCE and several of its metabolites. As part of a mini-monograph on key issues in the health risk assessment of TCE, this article is a review of a number of the current scientific issues in TCE pharmacokinetics and recent PBPK modeling efforts with a focus on literature published since 2000. Particular attention is paid to factors affecting PBPK modeling for application to risk assessment. Recent TCE PBPK modeling efforts, coupled with methodologic advances in characterizing uncertainty and variability, suggest that rigorous application of PBPK modeling to TCE risk assessment appears feasible at least for TCE and its major oxidative metabolites trichloroacetic acid and trichloroethanol. However, a number of basic structural hypotheses such as enterohepatic recirculation, plasma binding, and flow- or diffusion-limited treatment of tissue distribution require additional evaluation and analysis. Moreover, there are a number of metabolites of potential toxicologic interest, such as chloral, dichloroacetic acid, and those derived from glutathione conjugation, for which reliable pharmacokinetic data is sparse because of analytical difficulties or low concentrations in systemic circulation. It will be a challenge to develop reliable dosimetry for such cases.
Chiu
Weihsueh A
WA
National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC, USA. chiu.weihsueh@epa.gov
Okino
Miles S
MS
Lipscomb
John C
JC
Evans
Marina V
MV
D004781:Environmental Exposure / Q000009:adverse effects / Q000032:analysis; D004785:Environmental Pollutants / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity; D015386:Hazardous Substances / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity; D049674:History, 21st Century; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D014241:Trichloroethylene / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity; D014481:United States
D004785:Environmental Pollutants; D015386:Hazardous Substances; D014241:Trichloroethylene